Search research articles
Contact Us
Filters
Showing results (21-30 of 49) with videos related to
Page
of 5
Sort By:
Journal of Medicine
|
January 1, 1994
Lipid peroxidation and renal tubular damage in chronic pancreatic diseases: is there any relationship?
D Basso, M P Panozzo, M Plebani, et al.
Disease Markers
|
July 1, 1990
CAR-3 and CA 19-9 serum levels in pancreatic cancer: any differences between two epitopes of the same mucin-like glycoprotein?
T Meggiato, D Basso, C Fabris, et al.
Annali Italiani Di Medicina Interna : Organo Ufficiale Della Societa Italiana Di Medicina Interna
|
October 1, 1989
[Role of serum markers and or various clinical parameters in the diagnosis of pancreatic carcinoma]
T Meggiato, D Basso, A Piccoli, et al.
Acta Gastro-Enterologica Belgica
|
September 1, 1989
Acute phase proteins in chronic pancreatic disease
D Basso, C Fabris, G Del Favero, et al.
Tumori
|
February 28, 1991
Comparison of two newly identified tumor markers (CAR-3 and DU-PAN-2) with CA 19-9 in patients with pancreatic cancer
C Ferrara, D Basso, C Fabris, et al.
International Journal of Pancreatology : Official Journal of the International Association of Pancreatology
|
June 1, 1992
Urinary phospholipase A2 excretion in chronic pancreatic diseases
C Fabris, D Basso, M P Panozzo, et al.
Journal of Medicine
|
September 30, 1999
Transforming growth factor beta, fibrogenesis and hyperglycemia in patients with chronic pancreatitis
P Fogar, C Pasquali, D Basso, et al.
Pancreas
|
May 1, 1994
Beta-cell function in pancreatic adenocarcinoma
D Basso, M Plebani, P Fogar, et al.
Enzyme
|
January 1, 1989
Urinary elastase 1 in chronic pancreatic disease
C Fabris, D Basso, L Benini, et al.
British Journal of Cancer
|
March 1, 1991
Serum DU-PAN-2 in the differential diagnosis of pancreatic cancer: influence of jaundice and liver dysfunction
C Fabris, A Malesci, D Basso, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 49) with videos related to
Sort By:
Page
of 5
Journal of Medicine
|
January 1, 1994
Lipid peroxidation and renal tubular damage in chronic pancreatic diseases: is there any relationship?
D Basso, M P Panozzo, M Plebani, et al.
Disease Markers
|
July 1, 1990
CAR-3 and CA 19-9 serum levels in pancreatic cancer: any differences between two epitopes of the same mucin-like glycoprotein?
T Meggiato, D Basso, C Fabris, et al.
Annali Italiani Di Medicina Interna : Organo Ufficiale Della Societa Italiana Di Medicina Interna
|
October 1, 1989
[Role of serum markers and or various clinical parameters in the diagnosis of pancreatic carcinoma]
T Meggiato, D Basso, A Piccoli, et al.
Acta Gastro-Enterologica Belgica
|
September 1, 1989
Acute phase proteins in chronic pancreatic disease
D Basso, C Fabris, G Del Favero, et al.
Tumori
|
February 28, 1991
Comparison of two newly identified tumor markers (CAR-3 and DU-PAN-2) with CA 19-9 in patients with pancreatic cancer
C Ferrara, D Basso, C Fabris, et al.
International Journal of Pancreatology : Official Journal of the International Association of Pancreatology
|
June 1, 1992
Urinary phospholipase A2 excretion in chronic pancreatic diseases
C Fabris, D Basso, M P Panozzo, et al.
Journal of Medicine
|
September 30, 1999
Transforming growth factor beta, fibrogenesis and hyperglycemia in patients with chronic pancreatitis
P Fogar, C Pasquali, D Basso, et al.
Pancreas
|
May 1, 1994
Beta-cell function in pancreatic adenocarcinoma
D Basso, M Plebani, P Fogar, et al.
Enzyme
|
January 1, 1989
Urinary elastase 1 in chronic pancreatic disease
C Fabris, D Basso, L Benini, et al.
British Journal of Cancer
|
March 1, 1991
Serum DU-PAN-2 in the differential diagnosis of pancreatic cancer: influence of jaundice and liver dysfunction
C Fabris, A Malesci, D Basso, et al.
Page
of 5